HIMS
Hims & Hers Health, Inc. Class A · NYSE
- Sector Health Services
- Industry Medical/Nursing Services
- Website forhims.com
- Employees(FY) 651
- ISIN US4330001060
Performance
+24.32%
1W
+20.42%
1M
+45.95%
3M
+89.55%
6M
+163.03%
YTD
+233.48%
1Y
Profile
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
Technical Analysis of HIMS 2024-11-08
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-06 07:37
- 2024-11-05 19:00
HIMS: Lowering target price to $22.00(Argus Research)
- 2024-11-05 12:29
Trump vs. Harris trades, Boeing, Hims & Hers: Top Stories(Yahoo Finance Video)
- 2024-11-05 11:32
Stocks to Watch Tuesday: Palantir, Trump Media, Super Micro, Hims(The Wall Street Journal)
- 2024-11-05 03:11
- 2024-11-04 19:00
Hims & Hers Health jumps on earnings. CFO talks GLP-1 influences.(Yahoo Finance Video)
- 2024-11-04 16:59
IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory(Investor's Business Daily)
- 2024-11-04 16:05
- 2024-11-04 03:05
- 2024-10-29 09:00
- 2024-10-28 21:00
- 2024-10-27 11:47
- 2024-10-22 09:00
- 2024-10-21 21:00
- 2024-10-21 13:43
Hims & Hers Health Tops Growth 50 List As FDA OKs Cheaper Weight-Loss Drug(Investor's Business Daily)
- 2024-10-21 09:00
- 2024-10-20 21:00
- 2024-10-19 15:20
- 2024-10-17 07:06
3 US Growth Companies With Significant Insider Ownership(Simply Wall St.)
- 2024-10-16 16:19
Hims & Hers Shares Rallied 22% Over Two Days. Why That Move Is Now At Risk.(Investor's Business Daily)
- 2024-10-16 08:00
Hims & Hers Shares Have Rallied 22% This Week. Why That Move Is Now At Risk.(Investor's Business Daily)
- 2024-10-15 13:04
- 2024-10-15 07:16
- 2024-10-14 16:05
- 2024-10-14 15:40
Hims & Hers surges as FDA mulls over compounded drugs limit(Yahoo Finance Video)
- 2024-10-14 12:29
Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug(Investor's Business Daily)
- 2024-10-14 04:25
- 2024-10-14 04:05
- 2024-10-10 16:39
- 2024-10-10 16:39
Page 1 of 9
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.